name: dJ1043E3.1 Mutation Detection Reagent Kits


name: dJ137F1.4 Mutation Detection Reagent Kits


name: dJ188D3.1 Mutation Detection Reagent Kits


name: Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1 Deletion/Duplication Detection Reagent Kits


name: SERPINC1 Deletion/Duplication Detection Reagent Kits


name: THPH7 Deletion/Duplication Detection Reagent Kits


name: Fc Fragment of IgG Receptor IIIA Mutation Detection Reagent Kits


name: CD340 Deletion/Duplication Detection Reagent Kits


name: ERBB2 Deletion/Duplication Detection Reagent Kits


name: MLN 19 Deletion/Duplication Detection Reagent Kits


name: NGL Deletion/Duplication Detection Reagent Kits


name: TKR1 Deletion/Duplication Detection Reagent Kits


name: Cytochrome P450 Family 1 Subfamily A Member 2 Mutation Detection Reagent Kits


name: Cytochrome P450 Family 2 Subfamily B Member 6 Mutation Detection Reagent Kits


name: Cytochrome P450 Family 2 Subfamily C Member 19 Mutation Detection Reagent Kits


name: DNA Topoisomerase II Alpha Deletion/Duplication Detection Reagent Kits


name: TOP2A Deletion/Duplication Detection Reagent Kits


name: Major Histocompatibility Complex Class I Antigen HLA-B Heavy Chain Mutation Detection Reagent Kits


name: Major Histocompatibility Complex Class I Antigen HLA-A Heavy Chain Mutation Detection Reagent Kits


name: Microsatellite Instability Test Reagent/Kits


name: Protein C, Inactivator Of Coagulation Factors Va And VIIIa Mutation Detection Reagent Kits


name: PROS1 Deletion/Duplication Detection Reagent Kits


name: Protein S (Alpha) Deletion/Duplication Detection Reagent Kits


name: THPH5 Deletion/Duplication Detection Reagent Kits


name: THPH6 Deletion/Duplication Detection Reagent Kits


name: Protein S (Alpha) Mutation Detection Reagent Kits


name: Rh Blood Group D Antigen Mutation Detection Reagent Kits


name: SERPINC1 Mutation Detection Reagent Kits


name: Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1 Mutation Detection Reagent Kits


name: IVD Test Reagent Kits, Multimodal Assay, Gene Anomaly/Immunoassay/Immunohistochemistry-Immunocytochemistry


name: IVD Test Reagent/Kits, Immunoassay, Acute Kidney Injury


name: IVD Test Reagent/Kits, Molecular Assay, Donor-Derived Cell-Free Nucleic Acid, Organ Transplant Rejection


name: IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Hexanucleotide Repeats, GGGGCC, C9orf72 Gene


name: Controllers, Gas Concentration, Carbon Dioxide


name: Laboratory Incubator Carbon Dioxide Controllers


name: Aspirator/Suction Unit Collection Container Liners


name: Infusion Systems, Hydration, Closed-Loop


name: IVD Test Reagent/Kits, Cytology/Histology, Mass Cytometry


name: Image Processors, Blood Loss Quantifying


name: IVD Test Reagent/Kits, Molecular Assay, Epigenetic Modification, DNA Methylation, Panel, Male Fertility


name: IVD Panels, Human Genetics, Female Infertility


name: Female Reproductive Health Gene Panel Tests


name: Wound Therapy Systems, Topical Oxygen, Normobaric


name: Wound Therapy Systems, Topical Oxygen, Pressurized


name: Hyperthermic Intracavitary Chemotherapy Units


name: Surgical Sponge Blood Loss Imaging Systems


name: Suction Canister Blood Loss Imaging Systems


name: Pumps, Hyperthermic Intraperitoneal Chemotherapy


name: Hyperthermic Intrathoracic Chemotherapy Delivery Systems


name: Hyperthermic Intraperitoneal Chemotherapy Delivery Systems


name: Heated Intraperitoneal Chemotherapy Delivery Systems


name: IVD Panels, Human Genetics, Chromosome Breakage Disorders


name: IVD Panels, Human Genetics, Immunodeficiency, Primary, Autoimmune Lymphoproliferative Syndrome


name: IVD Panels, Human Genetics, Hemophagocytic Lymphohistiocytosis


name: IVD Panels, Human Genetics, Encephalopathy, Rett Syndrome/Angelman Syndrome


name: Lasers, Nd:YAG/Nd:YAG Frequency Doubled/Ruby, Dermatologic


name: Tinnitus Control Skin Patches, Topographical Filter


name: IVD Test Reagent/Kits, Molecular Assay, RNA Expression, Multiple Sclerosis


name: IVD Test Reagent/Kits, Molecular Assay, RNA Expression, Irritable Bowel Syndrome/Inflammatory Bowel Disease


name: IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, C19orf12


name: IVD Panels, Human Genetics, Cancer, Somatic, Gastrointestinal Stromal Tumors


name: Interventional Guide Wires, Cardiovascular


name: Parahydrogen-Induced Polarization (PHIP) Systems


name: Exercisers, Computer-Aided Training, Neuro-Physical Therapy


name: IVD Test Reagent/Kits, Molecular Assay, Mitochondrial Genome Sequencing, Human


name: IVD Panels, Human Genetics, Carrier Screening, Ethnicity-Based


name: IVD Panels, Human Genetics, Carrier Screening, Pan-Ethnic


name: IVD Test Reagent/Kits, Molecular Assay, Immune Cell Receptor Rearrangement


name: IVD Panels, Human Genetics, Hyperparathyroidism


name: IVD Panels, Human Genetics, Neurodevelopmental Disorder


name: IVD Panels, Human Genetics, Neurodevelopmental Disorder, Comprehensive


name: Breast Lesion Localization Implants, Tumor Resection Guidance System


name: Fiducial Markers, Implantable, Image-Guided Radiotherapy


name: IVD Test Reagent/Kits, Molecular Assay, In Situ Hybridization


name: Stereotactic Systems, Image-Guided, Dental


name: Analyzers, Point-of-Care, Whole Blood, Cotinine


name: Simulators, Tympanic Membrane Temperature


name: Monitors, Environmental, Air Humidity/Temperature


name: Scanning Systems, Magnetic Resonance Imaging, Neonatal Head


name: Push Button-Activated Safety Blood Lancets


name: Tumor Resection Guidance System, Magnetic Seeds


name: Tumor Resection Guidance System, Radiofrequency Identification Tag Implants


name: Tumor Resection Guidance System, Radar Reflector Implants


name: Tumor Resection Guidance Units, Electromagnetic


name: Non-Wire Breast Lesion Localization Systems


name: Wire-Free Breast Lesion Localization Systems


name: Stereotactic Body Radiation Therapy Fiducial Markers


name: Stereotactic Partial Breast Irradiation Fiducial Markers


name: IVD Panels, Human Genetics, Neurodegenerative Disorder, Basal Ganglia Calcification


name: IVD Panels, Human Genetics, Neurodegenerative Disorder, Dystonia


name: Fluorescent In Situ Hybridization [FISH] Kits


name: Chromogenic In Situ Hybridization [CISH] Kits


name: Superparamagnetic Iron Oxide (SPIO) Lymphatic Tracer


name: Automated Electrophoretic Gel Spot Cutters


name: Fiducial Markers, Image-Guided Radiotherapy


name: IVD Panels, Human Genetics, Neuromuscular Disorders, Congenital Myasthenic Syndromes/Arthrogryposis


name: Computer Assisted Dental Implant Surgery Systems


name: Tubing Sets, Air Bubble Detection/Removal System


name: Air Bubble Detection/Removal System Cartridges


name: IVD Panels, Human Genetics, Cardiac Disorder, Congenital Heart Defects


name: IVD Panels, Human Genetics, Eye Disorder, Ectopia Lentis, Mutation


name: IVD Panels, Human Genetics, Systemic Hypertension, Mutation


name: IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, MCM6


name: IVD Test Reagent/Kits, Immunoassay, Brain Trauma


name: Traumatic Brain Injury (TBI) Assessment Tests


name: Electronic Hand Hygiene Surveillance Systems


name: Software, Stereotactic System, Image-Guided Surgery, Dental


name: Aluminum Sesquichlorohydrate 0.15048 kg in 1 kg TOPICAL Lotion [Carpe Antiperspirant for Underarms]


name: CVS True Metrix Blood Glucose Test Strip


name: CVS True Metrix Self Monitoring Blood Glucose Meter


name: Hypochlorous Acid 0.01% Topical application Solution [HYPOCYN]


name: Similac Advance Lamehadrin Infant Formula with Iron Powder for Suspension


name: Similac Lamehadrin Toddler Drink Powder for Suspension (Vanilla)


name: HYALURONATE SODIUM 0.0014 g in 28 g TOPICAL CREAM [Miracle Laser Mask]


name: NIACINAMIDE 0.15 g in 30 g TOPICAL CREAM [TOAS Rejuvenation]


name: Formula, Infant Oral Suspension [ENFAMIL NEUROPRO GENTLEASE]


name: Formula, Infant Oral Powder for Suspension [ENFAMIL NEUROPRO ENFACARE]


name: Medical Food Oral Powder for Suspension [PURAMINO JR]


name: Formula, Infant Oral Suspension [ENFAMIL NEUROPRO ENFACARE]


name: OXYTETRACYCLINE HYDROCHLORIDE .99 kg in 1 kg NOT APPLICABLE POWDER [AX Pharmaceutical Corp]


name: ZINC OXIDE 0.1365 mg in 1 mL TOPICAL LOTION [Alive Prebiotic Balancing Moisturizer SPF 15]


name: nutritional therapy for impaired digestive function 13.7 gram-490 kcal/100 gram ORAL POWDER (GRAM)


name: sodium chloride/potassium chloride/sodium citrate/rice syrup 115 mg-40 mg-40 kcal/10.5 gram ORAL POWDER (GRAM)


name: sodium chloride/potassium chloride/sodium citrate/rice syrup 115 mg-40 mg-40 kcal/250 mL ORAL LIQUID (ML)


name: blood ketone and glucose monitor MISCELL EACH


name: CAPSULE,DEL RELEASE,EXT RELEASE SPRINKLE


name: nifedipine, micronized 100 % MISCELL POWDER (GRAM)


name: parenteral electrolytes combination no.30


name: dimethicone/dimethicone crossp/trimethylsil/silicone gel pad TOPICAL KIT


name: gel-matrix pad,silicone-dimethicone-dime-decameoct-oct-vit E 2" X 5.5" TOPICAL KIT


name: SPONGE,DRAIN 4IN X 4IN 12-PLY DYNAREX #4612


name: DRAINAGE,CONNECTOR TUBING 42CM MERIT #K10-04130


name: CATHETER FOLEY 2-WAY 18FR 10ML M#DYND11758


name: DRESSING,MEPILEX BORDER HEEL 8.7IN X 9.1IN


name: CATHETER,INTERMITTENT,GENTLECATH 12FR FEMALE #508990


name: CENTRAL LINE DRESSING CHANGE KIT RELIAMED #7097381


name: DRESSING,AQUACEL FOAM 4IN X 12IN #421155


name: CATHETER,INTERMITTENT 16FR RUSCH #220600-16


name: CATHERIZATION SET,FOLEY 18FR 10ML M#DYND160718


name: SPONGE,DRAIN 2IN X 2IN 6-PLY MEDLINE #NON256001


name: STOCKINETTE,COTTON,TUBULAR 4 5/7IN X 22YD ROLL


name: SET,INFUSION AUTOSOFT XC TANDEM #1001729


name: CATHETER,EXTERNAL MEDIUM ROCHESTER #39302/39102


name: TRACHEAL SUCTION SET 12FR COVIDIEN #31279


name: Hydralyte Oral Electrolyte Powder Color Free


name: Similasan Teething + Tooth Support Quick Diss


name: Cleanser;Lotion, Multi Ingredient;Shampoo, Multi Ingredient NA; NA; NA Topical application Kit [JOHNSON'S SLEEPY TIME BABY GIFT SET]


name: Lotion, Multi Ingredient;Shampoo, Multi Ingredient NA; NA Topical application Kit


name: SPF30 Sunscreen and Antibacterial Hand Sanitizer KIT


name: Titanium Dioxide 0.0575 g in 1 g / Zinc Oxide 0.049 g in 1 g TOPICAL POWDER [LBEL EFFET PARFAIT LONG LASTING COMPACT SPF 15 Claire 1/Beige]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 80 mg in 1 g / OCTOCRYLENE 55 mg in 1 g / OCTISALATE 20 mg in 1 g TOPICAL STICK [SPF15 Sunscreen]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 120 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 17 mg in 1 mL / OXYBENZONE 30 mg in 1 mL TOPICAL LOTION [Aveeno Positively Radiant Daily Moisturizer sunscreen Broad Spectrum SPF30]


name: HOMOSALATE 10 g in 100 g / OCTOCRYLENE 10 g in 100 g / AVOBENZONE 3 g in 100 g / OCTISALATE 5 g in 100 g TOPICAL LOTION [Sunscreen]


name: ZINC OXIDE 216 mg in 1 mL TOPICAL LOTION [Aveeno Positively Mineral Sensitive Skin Sunscreen Broad Spectrum SPF 50]


name: Niacinamide 0.5 g in 25 mL / Adenosine 0.01 g in 25 mL TOPICAL PATCH [Ra Sence Loe Cure Solu tion Aloe Mask]


name: Zinc Oxide;Cleanser;Cleanser;Lotion, Multi Ingredient;Shampoo, Multi Ingredient 40%; NA; NA; NA; NA Multiple Routes Kit


name: Zinc Oxide;Cleanser;Lotion, Multi Ingredient;Shampoo, Multi Ingredient 40%; NA; NA; NA Multiple Routes Kit


name: Zinc Oxide;Lotion, Multi Ingredient;Shampoo, Multi Ingredient;Shampoo, Multi Ingredient 13%; NA; NA; NA Topical application Kit


name: OCTINOXATE 6.9 g in 100 mL / OCTISALATE 3 g in 100 mL / ZINC OXIDE 4 g in 100 mL TOPICAL CREAM [CONTROL CORRECTIVE SUNSCREEN SPF-30]


name: HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 6 g in 100 g / AVOBENZONE 2.7 g in 100 g TOPICAL SPRAY [Banana Boat]


name: ALUMINUM CHLOROHYDRATE 78 mg in 1 mL TOPICAL LOTION [DawnMist Antiperspirant Deodorant]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 6 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL SPRAY [Banana Boat]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 ug in 1 g TOPICAL STICK [Softlips Cherry Cordial, Maple Butter, Frosted Berry]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [Everyday Coverage Tinted Sunscreen - Extra Light Tint]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 16 g in 100 g TOPICAL LOTION [Clear-N-Smooth]


name: DIMETHICONE 20 mg in 1 g TOPICAL STICK [Softlips Cherry, Raspberry, Vanilla]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 ug in 1 g TOPICAL STICK [Softlips Salted Caramel, Candy Apple, Marshmallow Ghost]


name: TITANIUM DIOXIDE 1.49 g in 15 g / Octinoxate 1.05 g in 15 g / Zinc Oxide 0.80 g in 15 g TOPICAL POWDER [ESMIA AIR CUSHION LIGHT BEIGE 21]


name: ZINC OXIDE 1 g in 1 g / TITANIUM DIOXIDE 1 g in 1 g TOPICAL LOTION [WL-AAE-ZT-O-391]


name: HOMOSALATE 6 g in 100 g / OCTOCRYLENE 6 g in 100 g / AVOBENZONE 2.7 g in 100 g TOPICAL SPRAY [Hawaiian Tropic]


name: POLYSORBATE 80 6.5 mg in 1 mL INTRAVENOUS SOLUTION


name: ZINC OXIDE 90 g in 1000 g / OCTINOXATE 75 g in 1000 g TOPICAL LOTION [EltaMD UV Clear SPF46]


name: Measurement of Anaplasma species antibody


name: Fine needle aspiration biopsy, without imaging guidance


name: Fine needle aspiration biopsy, without imaging guidance; each additional lesion (List separately in addition to code for primary procedure)


name: Fine needle aspiration biopsy, including ultrasound guidance


name: Fine needle aspiration biopsy, including ultrasound guidance; first lesion


name: Fine needle aspiration of first lesion using ultrasound guidance


name: Fine needle aspiration biopsy, including ultrasound guidance; each additional lesion (List separately in addition to code for primary procedure)


name: Fine needle aspiration biopsy, including fluoroscopic guidance


name: Fine needle aspiration biopsy, including fluoroscopic guidance; first lesion


name: Fine needle aspiration of first lesion using fluoroscopic guidance


name: Fine needle aspiration biopsy, including fluoroscopic guidance; each additional lesion (List separately in addition to code for primary procedure)


name: Fine needle aspiration biopsy, including CT guidance


name: Fine needle aspiration biopsy, including CT guidance; first lesion


name: Fine needle aspiration biopsy, including CT guidance; each additional lesion (List separately in addition to code for primary procedure)


name: Fine needle aspiration biopsy, including MR guidance


name: Fine needle aspiration biopsy, including MR guidance; first lesion


name: Fine needle aspiration biopsy, including MR guidance; each additional lesion (List separately in addition to code for primary procedure)


name: Tangential biopsy of skin (eg, shave, scoop, saucerize, curette)


name: Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion


name: Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); each separate/additional lesion (List separately in addition to code for primary procedure)


name: tangential biopsy of skin, additional lesion


name: Punch biopsy of skin (including simple closure, when performed)


name: Punch biopsy of skin (including simple closure, when performed); single lesion


name: Punch biopsy of single lesion of skin with simple closure


name: Punch biopsy of skin (including simple closure, when performed); each separate/additional lesion (List separately in addition to code for primary procedure)


name: punch biopsy of skin, each separate/additional lesion


name: Incisional biopsy of skin (eg, wedge) (including simple closure, when performed)


name: Incisional biopsy of skin (eg, wedge) (including simple closure, when performed); single lesion


name: Incisional biopsy of single lesion of skin with simple closure


name: Incisional biopsy of skin (eg, wedge) (including simple closure, when performed); each separate/additional lesion (List separately in addition to code for primary procedure)


name: incisional biopsy of skin, each separate / additional lesion


name: Allograft, includes templating, cutting, placement and internal fixation, when performed


name: Allograft, includes templating, cutting, placement and internal fixation, when performed; osteoarticular, including articular surface and contiguous bone (List separately in addition to code for primary procedure)


name: Allograft of articular surface and contiguous bone


name: Allograft, includes templating, cutting, placement and internal fixation, when performed; hemicortical intercalary, partial (ie, hemicylindrical) (List separately in addition to code for primary procedure)


name: Partial hemicortical intercalary allograft of bone


name: Allograft, includes templating, cutting, placement and internal fixation, when performed; intercalary, complete (ie, cylindrical) (List separately in addition to code for primary procedure)


name: Injection procedure for contrast knee arthrography or contrast enhanced CT/MRI knee arthrography


name: Injection of contrast for imaging of knee joint


name: Transcatheter insertion or replacement of permanent leadless pacemaker, right ventricular, including imaging guidance (eg, fluoroscopy, venous ultrasound, ventriculography, femoral venography) and device evaluation (eg, interrogation or programming), when performed


name: Transcatheter insertion of permanent leadless right ventricular pacemaker


name: Transcatheter insertion of permanent leadless right ventricular pacemaker using imaging guidance


name: Transcatheter insertion of permanent leadless right ventricular pacemaker using imaging guidance and device evaluation


name: Transcatheter insertion of permanent leadless right ventricular pacemaker with device evaluation


name: Transcatheter replacement of permanent leadless right ventricular pacemaker using imaging guidance


name: transcatheter removal of permanent right ventricular leadless pacemaker


name: Introduction or Removal of Subcutaneous Cardiac Rhythm Monitor


name: Insertion, subcutaneous cardiac rhythm monitor, including programming


name: Insertion of heart rhythm monitor under skin


name: Insertion and programming of subcutaneous cardiac rhythm monitor


name: Removal, subcutaneous cardiac rhythm monitor


name: Removal of heart rhythm monitor from under the skin


name: Transcatheter implantation of wireless pulmonary artery pressure sensor for long-term hemodynamic monitoring, including deployment and calibration of the sensor, right heart catheterization, selective pulmonary catheterization, radiological supervision and interpretation, and pulmonary artery angiography, when performed


name: Transcatheter implantation of wireless pulmonary artery pressure sensor for long-term hemodynamic monitoring


name: Replacement, aortic valve; by translocation of autologous pulmonary valve and transventricular aortic annulus enlargement of the left ventricular outflow tract with valved conduit replacement of pulmonary valve (Ross-Konno procedure)


name: Replacement of aortic valve by translocation of autologous pulmonary valve and transventricular aortic annulus enlargement of left ventricular outflow tract with valved conduit replacement of pulmonary valve


name: Aortic hemiarch graft including isolation and control of the arch vessels, beveled open distal aortic anastomosis extending under one or more of the arch vessels, and total circulatory arrest or isolated cerebral perfusion (List separately in addition to code for primary procedure)


name: Aortic hemiarch graft with isolated cerebral perfusion


name: Aortic hemiarch graft with total circulatory arrest


name: Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance


name: Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, including all imaging guidance, image documentation, and all associated radiological supervision and interpretation required to perform the insertion


name: Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, including all imaging guidance, image documentation, and all associated radiological supervision and interpretation required to perform the insertion; younger than 5 years of age


name: Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, including all imaging guidance, image documentation, and all associated radiological supervision and interpretation required to perform the insertion; age 5 years or older


name: Biopsy or excision of lymph node(s); open, inguinofemoral node(s)


name: Open biopsy of multiple inguinofemoral lymph nodes


name: Open biopsy of single inguinofemoral lymph node


name: Open excision of multiple inguinofemoral lymph nodes


name: Open excision of single inguinofemoral lymph node


name: Replacement of gastrostomy tube, percutaneous, includes removal, when performed, without imaging or endoscopic guidance


name: Replacement of gastrostomy tube, percutaneous, includes removal, when performed, without imaging or endoscopic guidance; not requiring revision of gastrostomy tract


name: Percutaneous removal and replacement of gastrostomy tube


name: Percutaneous replacement of gastrostomy tube


name: Replacement of gastrostomy tube, percutaneous, includes removal, when performed, without imaging or endoscopic guidance; requiring revision of gastrostomy tract


name: Percutaneous removal and replacement of gastrostomy tube with revision of gastrostomy tract


name: Percutaneous replacement of gastrostomy tube with revision of gastrostomy tract


name: Dilation of existing tract, percutaneous, for an endourologic procedure including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation, with postprocedure tube placement, when performed


name: Percutaneous dilation of existing tract for endourologic procedure using imaging guidance with radiological supervision and interpretation


name: Dilation of existing tract, percutaneous, for an endourologic procedure including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation, with postprocedure tube placement, when performed; including new access into the renal collecting system


name: Percutaneous dilation of existing tract with new access into the renal collecting system for endourologic procedure using fluoroscopic guidance with radiological supervision and interpretation


name: Percutaneous dilation of existing tract with new access into the renal collecting system for endourologic procedure using imaging guidance with radiological supervision and interpretation


name: Percutaneous dilation of existing tract with new access into the renal collecting system for endourologic procedure using ultrasound and fluoroscopic guidance with radiological supervision and interpretation


name: Percutaneous dilation of existing tract with new access into the renal collecting system for endourologic procedure using ultrasound guidance with radiological supervision and interpretation


name: Transurethral destruction of prostate tissue; by radiofrequency generated water vapor thermotherapy


name: Repair of protrusion of inner tissue through eyeball with graft


name: Ultrasound, targeted dynamic microbubble sonographic contrast characterization (non-cardiac)


name: Ultrasound, targeted dynamic microbubble sonographic contrast characterization (non-cardiac); initial lesion


name: Ultrasound, targeted dynamic microbubble sonographic contrast characterization (non-cardiac); each additional lesion with separate injection (List separately in addition to code for primary procedure)


name: Ultrasound, elastography; parenchyma (eg, organ)


name: Ultrasound elastography of parenchymal tissue


name: Ultrasound, elastography; first target lesion


name: Ultrasound, elastography; each additional target lesion (List separately in addition to code for primary procedure)


name: Ultrasound elastography of additional target lesion


name: Magnetic resonance imaging, breast, without contrast material


name: Magnetic resonance imaging, breast, without contrast material; unilateral


name: Magnetic resonance imaging, breast, without contrast material; bilateral


name: Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed


name: Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; unilateral


name: Magnetic resonance imaging, breast, without and with contrast material(s), including computer-aided detection (CAD real-time lesion detection, characterization and pharmacokinetic analysis), when performed; bilateral


name: BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis


name: Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants


name: BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis


name: Gene analysis (breast cancer 1 and 2) of full sequence


name: BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)


name: Gene analysis (breast cancer 1 and 2) for duplication or deletion variants


name: Gene analysis (breast cancer 1 and 2) for 185delAG, 5385insC, 6174delT variants


name: BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis


name: BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis


name: Gene analysis (breast cancer 1) of full sequence


name: Breast cancer 1 (BRCA1) full sequence gene analysis


name: BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)


name: Gene analysis (breast cancer 1) for duplication or deletion variants


name: BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis


name: BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements)


name: Gene analysis (breast cancer 2) for duplication or deletion variants


name: Gene analysis (breast cancer 2) of full sequence


name: AFF2 (ALF transcription elongation factor 2 [FMR2]) (eg, fragile X intellectual disability 2 [FRAXE]) gene analysis; evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (fragile X intellectual disability 2) for detection of abnormal alleles


name: AFF2 (ALF transcription elongation factor 2 [FMR2]) (eg, fragile X intellectual disability 2 [FRAXE]) gene analysis; characterization of alleles (eg, expanded size and methylation status)


name: Gene analysis (fragile X intellectual disability 2) for characterization of alleles


name: AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis


name: AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; full gene sequence


name: Gene analysis (androgen receptor) of full sequence


name: AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; known familial variant


name: Gene analysis (androgen receptor) for known familial variant


name: Androgen receptor (AR) gene analysis for detection of known familial variant


name: AR (androgen receptor) (eg, spinal and bulbar muscular atrophy, Kennedy disease, X chromosome inactivation) gene analysis; characterization of alleles (eg, expanded size or methylation status)


name: Gene analysis (androgen receptor) for characterization of alleles


name: Androgen receptor (AR) gene analysis for characterization of alleles


name: ATN1 (atrophin 1) (eg, dentatorubral-pallidoluysian atrophy) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (atropin 1) for abnormal alleles


name: Atrophin 1 (ATN1) gene analysis for detection of abnormal alleles


name: ATXN1 (ataxin 1) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (ataxin 1) for abnormal alleles


name: Ataxin 1 (ATXN1) gene analysis for detection of abnormal alleles


name: ATXN2 (ataxin 2) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (ataxin 2) for abnormal alleles


name: Ataxin 2 (ATXN2) gene analysis for detection of abnormal alleles


name: ATXN3 (ataxin 3) (eg, spinocerebellar ataxia, Machado-Joseph disease) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (ataxin 3) for abnormal alleles


name: Ataxin 3 (ATXN3) gene analysis for detection of abnormal alleles


name: ATXN7 (ataxin 7) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (ataxin 7) for abnormal alleles


name: ATXN8OS (ATXN8 opposite strand [non-protein coding]) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (ataxin 8 opposite strand [non-protein coding]) for abnormal alleles


name: ATXN10 (ataxin 10) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (ataxin 10) for abnormal alleles


name: Ataxin 10 (ATXN10) gene analysis for detection of abnormal alleles


name: CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis


name: CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis; evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (calcium voltage-gated channel subunit alpha1 A) for abnormal alleles


name: Calcium voltage-gated channel subunit alpha1 A (CACNA1A) gene analysis for detection of abnormal alleles


name: CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis; full gene sequence


name: Gene analysis (calcium voltage-gated channel subunit alpha1 A) of full sequence


name: Calcium voltage-gated channel subunit alpha1 A (CACNA1A) full gene sequence analysis


name: CACNA1A (calcium voltage-gated channel subunit alpha1 A) (eg, spinocerebellar ataxia) gene analysis; known familial variant


name: Gene analysis (calcium voltage-gated channel subunit alpha1 A) for known familial variant


name: Calcium voltage-gated channel subunit alpha1 A (CACNA1A) gene analysis for detection of known familial variant


name: CNBP (CCHC-type zinc finger nucleic acid binding protein) (eg, myotonic dystrophy type 2) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (CCH-type zinc finger nucleic acid binding protein) for abnormal alleles


name: CCHC-type zinc finger nucleic acid binding protein (CNBP) gene analysis for detection of abnormal alleles


name: CSTB (cystatin B) (eg, Unverricht-Lundborg disease) gene analysis


name: CSTB (cystatin B) (eg, Unverricht-Lundborg disease) gene analysis; evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (cystatin B) for abnormal alleles


name: Cystatin B (CSTB) gene analysis for detection of abnormal alleles


name: CSTB (cystatin B) (eg, Unverricht-Lundborg disease) gene analysis; full gene sequence


name: Gene analysis (cystatin B) of full sequence


name: Cystatin B (CSTB) full sequence gene analysis


name: CSTB (cystatin B) (eg, Unverricht-Lundborg disease) gene analysis; known familial variant(s)


name: Gene analysis (cystatin B) for known familial variants


name: Cystatin B (CSTB) gene analysis for detection of known familial variant


name: BTK (Bruton's tyrosine kinase) (eg, chronic lymphocytic leukemia) gene analysis, common variants (eg, C481S, C481R, C481F)


name: Gene analysis (Bruton's tyrosine kinase) for common variants


name: Bruton's tyrosine kinase (BTK) gene analysis for detection of common variant


name: DMPK (DM1 protein kinase) (eg, myotonic dystrophy type 1) gene analysis


name: DMPK (DM1 protein kinase) (eg, myotonic dystrophy type 1) gene analysis; evaluation to detect abnormal (expanded) alleles


name: Gene analysis (DM1 protein kinase) for abnormal alleles


name: DM1 protein kinase (DMPK) gene analysis for detection of abnormal alleles


name: DMPK (DM1 protein kinase) (eg, myotonic dystrophy type 1) gene analysis; characterization of alleles (eg, expanded size)


name: Gene analysis (DM1 protein kinase) for characterization of alleles


name: DM1 protein kinase (DMPK) gene analysis for characterization of alleles


name: EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (eg, myelodysplastic syndrome, myeloproliferative neoplasms) gene analysis, full gene sequence


name: Gene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) of full sequence


name: Enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) full sequence gene analysis


name: EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) (eg, diffuse large B-cell lymphoma) gene analysis, common variant(s) (eg, codon 646)


name: Gene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) for common variants


name: Enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) gene analysis for detection of common variant


name: HTT (huntingtin) (eg, Huntington disease) gene analysis


name: HTT (huntingtin) (eg, Huntington disease) gene analysis; evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (Huntingtin) for abnormal alleles


name: HTT (huntingtin) (eg, Huntington disease) gene analysis; characterization of alleles (eg, expanded size)


name: Gene analysis (Huntingtin) for characterization of alleles


name: FXN (frataxin) (eg, Friedreich ataxia) gene analysis


name: FXN (frataxin) (eg, Friedreich ataxia) gene analysis; evaluation to detect abnormal (expanded) alleles


name: Gene analysis (frataxin) for abnormal alleles


name: FXN (frataxin) (eg, Friedreich ataxia) gene analysis; characterization of alleles (eg, expanded size)


name: Gene analysis (frataxin) for characterization of alleles


name: Frataxin (FXN) gene analysis for characterization of alleles


name: FXN (frataxin) (eg, Friedreich ataxia) gene analysis; full gene sequence


name: Gene analysis (frataxin) of full sequence


name: FXN (frataxin) (eg, Friedreich ataxia) gene analysis; known familial variant(s)


name: Gene analysis (frataxin) for known familial variants


name: Frataxin (FXN) gene analysis for detection of known familial variant


name: Gene analysis (O-6-methylguanine-DNA methyltransferase) for promoter methylation


name: O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation analysis


name: MYD88 (myeloid differentiation primary response 88) (eg, Waldenstrom's macroglobulinemia, lymphoplasmacytic leukemia) gene analysis, p.Leu265Pro (L265P) variant


name: Gene analysis (myeloid differentiation primary response 88) for p.Leu265Pro variant


name: Myeloid differentiation primary response 88 (MYD88) gene analysis for detection of p.Leu265Pro (L265P) variant


name: NUDT15 (nudix hydrolase 15) (eg, drug metabolism) gene analysis, common variant(s) (eg, *2, *3, *4, *5, *6)


name: Gene analysis (nudix hydrolase 15) for common variants


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of common variants


name: PABPN1 (poly[A] binding protein nuclear 1) (eg, oculopharyngeal muscular dystrophy) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (poly[A] binding protein nuclear 1) for abnormal alleles


name: Poly[A] binding protein nuclear 1 (PABPN1) gene analysis for detection of abnormal alleles


name: PLCG2 (phospholipase C gamma 2) (eg, chronic lymphocytic leukemia) gene analysis, common variants (eg, R665W, S707F, L845F)


name: Gene analysis (phospholipase C gamma 2) for common variants


name: Phospholipase C gamma 2 (PLCG2) gene analysis for detection of common variants


name: Gene analysis (Septin9) for promoter methylation


name: Septin9 (SEPT9) promoter methylation analysis


name: SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis


name: SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; dosage/deletion analysis (eg, carrier testing), includes SMN2 (survival of motor neuron 2, centromeric) analysis, if performed


name: Gene analysis (survival of motor neuron 1, telomeric) for dosage/deletion


name: Survival of motor neuron 1, telomeric (SMN1) dosage and deletion analysis


name: Survival of motor neuron 1, telomeric (SMN1) dosage and deletion analysis and survival of motor neuron 2, centromeric (SMN2) gene analysis


name: SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; full gene sequence


name: Gene analysis (survival of motor neuron 1, telomeric) of full sequence


name: SMN1 (survival of motor neuron 1, telomeric) (eg, spinal muscular atrophy) gene analysis; known familial sequence variant(s)


name: Gene analysis (survival of motor neuron 1, telomeric) for known familial sequence variants


name: Survival of motor neuron 1, telomeric (SMN1) gene analysis for detection of known familial sequence variant


name: TGFBI (transforming growth factor beta-induced) (eg, corneal dystrophy) gene analysis, common variants (eg, R124H, R124C, R124L, R555W, R555Q)


name: Gene analysis (transforming growth factor beta-induced) for common variants


name: Transforming growth factor beta-induced (TGFBI) gene analysis for detection of common variants


name: PPP2R2B (protein phosphatase 2 regulatory subunit Bbeta) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (protein phosphatase 2 regulatory subunit Bbeta) for abnormal alleles


name: Protein phosphatase 2 regulatory subunit Bbeta (PPP2R2B) gene analysis for detection of abnormal alleles


name: TBP (TATA box binding protein) (eg, spinocerebellar ataxia) gene analysis, evaluation to detect abnormal (eg, expanded) alleles


name: Gene analysis (TATA box binding protein) for abnormal alleles


name: TATA box binding protein (TBP) gene analysis for detection of abnormal alleles


name: TERT (telomerase reverse transcriptase) (eg, thyroid carcinoma, glioblastoma multiforme) gene analysis, targeted sequence analysis (eg, promoter region)


name: Gene analysis (telomerase reverse transcriptase) targeted sequence analysis


name: Telomerase reverse transcriptase (TERT) targeted sequence gene analysis


name: Genetic testing for severe inherited conditions (eg, cystic fibrosis, Ashkenazi Jewish-associated disorders [eg, Bloom syndrome, Canavan disease, Fanconi anemia type C, mucolipidosis type VI, Gaucher disease, Tay-Sachs disease], beta hemoglobinopathies, phenylketonuria, galactosemia), genomic sequence analysis panel, must include sequencing of at least 15 genes (eg, ACADM, ARSA, ASPA, ATP7B, BCKDHA, BCKDHB, BLM, CFTR, DHCR7, FANCC, G6PC, GAA, GALT, GBA, GBE1, HBB, HEXA, IKBKAP, MCOLN1, PAH)


name: Genomic sequence analysis panel for severe inherited conditions with sequencing of 15 or more genes


name: Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 11 genes (7 content and 4 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithms reported as percentage risk for metastatic recurrence and likelihood of benefit from extended endocrine therapy


name: Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver


name: Biochemical assays for evaluation of chronic Hepatitis C virus infection


name: Lipoprotein, direct measurement; small dense LDL cholesterol


name: Measurement of small dense low density lipoprotein cholesterol


name: Direct measurement of small dense low densitiy lipoprotein cholesterol


name: MicroRNA gene analysis of thyroid nodule tissue


name: Cancer RNA gene expression profiling by whole transcriptome sequencing in formalin-fixed paraffin embedded tissue, predictive algorithm reported as potential targets for therapeutic agents


name: Cancer RNA gene expression profiling by whole transcriptome sequencing in fresh frozen tissue, predictive algorithm reported as potential targets for therapeutic agents


name: Detection of 8 autoantibodies in prostate tissue


name: Detection of autoantibodies ARF 6, NKX3-1, 5-UTR-BMI1, CEP 164, 3-UTR-Ropporin, Desmocollin, AURKAIP-1, and CSNK2A2 in serum using multiplexed immunoassay and flow cytometry for assessment of prostate cancer risk, algorithm reported as risk score


name: DNA gene analysis for acute myelogenous leukemia


name: Glycosylated acute phase proteins (GlycA), nuclear magnetic resonance spectroscopy, quantitative


name: Measurement of glycosylated acute phase proteins


name: Tenofovir, by liquid chromatography with tandem mass spectrometry (LC-MS/MS), urine, quantitative


name: Oncology (thyroid), DNA and mRNA of 112 genes, next-generation sequencing, fine needle aspirate of thyroid nodule, algorithmic analysis reported as a categorical result ("Positive, high probability of malignancy" or "Negative, low probability of malignancy")


name: DNA and microRNA gene analysis of thyroid nodule tissue


name: JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, targeted sequence analysis exons 12-15


name: Gene analysis (Janus kinase 2) of targeted sequence exons 12-15


name: Drug metabolism (adverse drug reactions and drug response), targeted sequence analysis (ie, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, CYP4F2, SLCO1B1, VKORC1 and rs12777823)


name: Gene analysis of targeted sequences for adverse drug reactions and drug response


name: Drug metabolism (warfarin drug response), targeted sequence analysis (ie, CYP2C9, CYP4F2, VKORC1, rs12777823)


name: Gene analysis of targeted sequences for warfarin drug response


name: Gene analysis (cytochrome P450 family 1, subfamily A, member 2) for common variants


name: Cytochrome P450, family 1, subfamily A, member 2 (CYP1A2) gene analysis for detection of common variants


name: Gene analysis (catechol-O-methyltransferase) for c.472G>A (rs4680) variant


name: Catechol-O-methyltransferase (COMT) gene analysis for detection of c.472G>A (rs4680) variant


name: HTR2A (5-hydroxytryptamine receptor 2A), HTR2C (5-hydroxytryptamine receptor 2C) (eg, citalopram metabolism) gene analysis, common variants (ie, HTR2A rs7997012 [c.614-2211T>C], HTR2C rs3813929 [c.-759C>T] and rs1414334 [c.551-3008C>G])


name: Gene analysis (5-hydroxytryptamine receptor 2A) for common variants


name: 5-hydroxytryptamine receptor 2A (HTR2A) and 5-hydroxytryptamine receptor 2C (HTR2C) gene analysis for detection of common variants


name: TPMT (thiopurine S-methyltransferase), NUDT15 (nudix hydroxylase 15) (eg, thiopurine metabolism) gene analysis, common variants (ie, TPMT *2, *3A, *3B, *3C, *4, *5, *6, *8, *12; NUDT15 *3, *4, *5)


name: Thiopurine S-methyltransferase (TPMT) and Nudix hydroxylase 15 (NUDT15) gene analysis for detection of common variants


name: Neurology (prion disease), cerebrospinal fluid, detection of prion protein by quaking-induced conformational conversion, qualitative


name: Testing for presence of prion protein in cerebrospinal fluid


name: Qualitative detection of prion protein in cerebrospinal fluid using quaking-induced conformational conversion


name: Exome (ie, somatic mutations), paired formalin-fixed paraffin-embedded tumor tissue and normal specimen, sequence analyses


name: Exome gene analysis for somatic mutation in tumor tissue


name: Exome gene sequence analysis in paired formalin-fixed paraffin embedded tumor tissue and normal specimen


name: Targeted genomic sequence analysis, solid organ neoplasm, DNA analysis of 324 genes, interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability and tumor mutational burden


name: DNA gene analysis of 324 genes in solid organ tumor tissue


name: Acute myelogenous leukemia targeted DNA sequencing analysis of 324 genes with interrogation for sequence variants, gene copy number amplifications, gene rearrangements, microsatellite instability, and tumor mutational burden


name: Vitamin D, 25 hydroxy D2 and D3, by LC-MS/MS, serum microsample, quantitative


name: Deoxyribonucleic acid (DNA) antibody, double stranded, high avidity


name: Assay for high-avidity anti double-stranded DNA antibody


name: BCR/ABL1 (t(9;22)) (eg, chronic myelogenous leukemia) translocation analysis, major breakpoint, quantitative


name: Gene analysis (t(9;22)) for translocation analysis


name: Borrelia burgdorferi, antibody detection of 5 recombinant protein groups, by immunoblot, IgM


name: IgM antibody detection test for Borrelia burgdorferi


name: Detection of Borrelia burgdorferi IgM antibody to 5 recombinant protein groups using immunoblot


name: Borrelia burgdorferi, antibody detection of 12 recombinant protein groups, by immunoblot, IgG


name: IgG antibody detection test for Borrelia burgdorferi


name: Detection of Borrelia burgdorferi IgG antibody to 12 recombinant protein groups using immunoblot


name: Tick-borne relapsing fever Borrelia group, antibody detection to 4 recombinant protein groups, by immunoblot, IgM


name: IgM antibody detection test for Tick-Borne Relapsing Fever Borrelia group (IgG)


name: Tick-borne relapsing fever Borrelia group, antibody detection to 4 recombinant protein groups, by immunoblot, IgG


name: Oncology (breast ductal carcinoma in situ), mRNA, gene expression profiling by real-time RT-PCR of 12 genes (7 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as recurrence score


name: mRNA gene analysis of 12 genes in breast ductal carcinoma in situ tumor tissue


name: FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia) internal tandem duplication (ITD) variants, quantitative


name: Oncology (prostate), mRNA, gene expression profiling by real-time RT-PCR of 17 genes (12 content and 5 housekeeping), utilizing formalin-fixed paraffin-embedded tissue, algorithm reported as a risk score


name: mRNA gene analysis of 17 genes in prostate tumor tissue


name: Oncology (solid organ neoplasia), DNA, targeted sequencing of protein-coding exons of 468 cancer-associated genes, including interrogation for somatic mutations and microsatellite instability, matched with normal specimens, utilizing formalin-fixed paraffin-embedded tumor tissue, report of clinically significant mutation(s)


name: DNA gene analysis of 468 genes in solid organ tumor tissue


name: NPM1 (nucleophosmin) (eg, acute myeloid leukemia) gene analysis, quantitative


name: Nucleophosmin (NPM1) quantitative gene analysis


name: Targeted genomic sequence analysis panel, acute myelogenous leukemia, DNA analysis, 194 genes, interrogation for sequence variants, copy number variants or rearrangements


name: DNA gene analysis of targeted sequences in 194 genes for acute myelogenous leukemia


name: Acute myelogenous leukemia targeted DNA sequencing analysis of 194 genes with interrogation for sequence variants, copy number variants or rearrangements


name: Prescription drug monitoring, evaluation of drugs present by liquid chromatography tandem mass spectrometry (LC-MS/MS), urine or blood, 31 drug panel, reported as quantitative results, detected or not detected, per date of service


name: Lipoprotein, blood, high resolution fractionation and quantitation of lipoproteins, including all five major lipoprotein classes and subclasses of HDL, LDL, and VLDL by vertical auto profile ultracentrifugation


name: Measurement of all five major lipoprotein classes and subclasses in blood


name: Prescription drug monitoring, 14 or more classes of drugs and substances, definitive tandem mass spectrometry with chromatography, capillary blood, quantitative report with therapeutic and toxic ranges, including steady-state range for the prescribed dose when detected, per date of service


name: Measurement of 14 or more drug classes in capillary blood


name: Prescription drug monitoring of 14 or more classes of drugs and substances in capillary blood using definitive tandem mass spectrometry with chromatography, with quantitative reporting of therapeutic and toxic ranges and steady-state range for prescribed dose


name: Cardiology (heart transplant), cell-free DNA, PCR assay of 96 DNA target sequences (94 single nucleotide polymorphism targets and two control targets), plasma


name: DNA gene analysis of 96 target sequences in plasma for heart transplant


name: Measurement of antibodies to Merkel cell polyoma virus oncoprotein in serum


name: Oncology (Merkel cell carcinoma), detection of antibodies to the Merkel cell polyoma virus capsid protein (VP1), serum, reported as positive or negative


name: Test for presence of antibodies to Merkel cell polyoma virus oncoprotein in serum


name: Twin zygosity, genomic-targeted sequence analysis of chromosome 2, using circulating cell-free fetal DNA in maternal blood


name: Gene analysis for identical twins in maternal blood


name: Transcutaneous measurement of five biomarkers (tissue oxygenation [StO2], oxyhemoglobin [ctHbO2], deoxyhemoglobin [ctHbR], papillary and reticular dermal hemoglobin concentrations [ctHb1 and ctHb2]), using spatial frequency domain imaging (SFDI) and multi-spectral analysis


name: Spatial frequency domain imaging of skin


name: Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use


name: Electroretinography (ERG), with interpretation and report


name: Electroretinography (ERG), with interpretation and report; full field (ie, ffERG, flash ERG, Ganzfeld ERG)


name: Electroretinography (ERG), with interpretation and report; multifocal (mfERG)


name: Implantable, Insertable, and Wearable Cardiac Device Evaluations


name: Remote monitoring of a wireless pulmonary artery pressure sensor for up to 30 days, including at least weekly downloads of pulmonary artery pressure recordings, interpretation(s), trend analysis, and report(s) by a physician or other qualified health care professional


name: Car seat/bed testing for airway integrity, for infants through 12 months of age, with continual clinical staff observation and continuous recording of pulse oximetry, heart rate and respiratory rate, with interpretation and report


name: Electrocorticogram from an implanted brain neurostimulator pulse generator/transmitter, including recording, with interpretation and written report, up to 30 days


name: Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional


name: Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with simple cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional


name: Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with complex cranial nerve neurostimulator pulse generator/transmitter programming by physician or other qualified health care professional


name: Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with brain neurostimulator pulse generator/transmitter programming, first 15 minutes face-to-face time with physician or other qualified health care professional


name: Electronic analysis of implanted neurostimulator pulse generator/transmitter (eg, contact group[s], interleaving, amplitude, pulse width, frequency [Hz], on/off cycling, burst, magnet mode, dose lockout, patient selectable parameters, responsive neurostimulation, detection algorithms, closed loop parameters, and passive parameters) by physician or other qualified health care professional; with brain neurostimulator pulse generator/transmitter programming, each additional 15 minutes face-to-face time with physician or other qualified health care professional (List separately in addition to code for primary procedure)


name: Assessment of Aphasia and Cognitive Performance Testing


name: Developmental/Behavioral Screening and Testing


name: Developmental test administration (including assessment of fine and/or gross motor, language, cognitive level, social, memory and/or executive functions by standardized developmental instruments when performed), by physician or other qualified health care professional, with interpretation and report


name: Developmental test administration (including assessment of fine and/or gross motor, language, cognitive level, social, memory and/or executive functions by standardized developmental instruments when performed), by physician or other qualified health care professional, with interpretation and report; first hour


name: Developmental test administration (including assessment of fine and/or gross motor, language, cognitive level, social, memory and/or executive functions by standardized developmental instruments when performed), by physician or other qualified health care professional, with interpretation and report; each additional 30 minutes (List separately in addition to code for primary procedure)


name: Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professional, both face-to-face time with the patient and time interpreting test results and preparing the report


name: Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professional, both face-to-face time with the patient and time interpreting test results and preparing the report; each additional hour (List separately in addition to code for primary procedure)


name: Psychological and Neuropsychological Testing Evaluation Services


name: Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed


name: Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour


name: Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; each additional hour (List separately in addition to code for primary procedure)


name: Neuropsychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed


name: Neuropsychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; first hour


name: Neuropsychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed; each additional hour (List separately in addition to code for primary procedure)


name: Psychological and Neuropsychological Test Administration and Scoring


name: Psychological or neuropsychological test administration and scoring by physician or other qualified health care professional, two or more tests, any method


name: Psychological or neuropsychological test administration and scoring by physician or other qualified health care professional, two or more tests, any method; first 30 minutes


name: Psychological or neuropsychological test administration and scoring by physician or other qualified health care professional, two or more tests, any method; each additional 30 minutes (List separately in addition to code for primary procedure)


name: Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method


name: Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; first 30 minutes


name: Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method; each additional 30 minutes (List separately in addition to code for primary procedure)


name: Psychological or neuropsychological test administration, with single automated, standardized instrument via electronic platform, with automated result only


name: Administration of neuropsychological test with single automated, standardized instrument via electronic platform, with automated result only


name: Administration of psychological test with single automated, standardized instrument via electronic platform, with automated result only


name: Behavior identification assessment, administered by a physician or other qualified health care professional, each 15 minutes of the physician's or other qualified health care professional's time face-to-face with patient and/or guardian(s)/caregiver(s) administering assessments and discussing findings and recommendations, and non-face-to-face analyzing past data, scoring/interpreting the assessment, and preparing the report/treatment plan


name: Behavior identification-supporting assessment, administered by one technician under the direction of a physician or other qualified health care professional, face-to-face with the patient, each 15 minutes


name: Group adaptive behavior treatment by protocol, administered by technician under the direction of a physician or other qualified health care professional, face-to-face with two or more patients, each 15 minutes


name: Adaptive behavior treatment with protocol modification, administered by physician or other qualified health care professional, which may include simultaneous direction of technician, face-to-face with one patient, each 15 minutes


name: Family adaptive behavior treatment guidance, administered by physician or other qualified health care professional (with or without the patient present), face-to-face with guardian(s)/caregiver(s), each 15 minutes


name: Multiple-family group adaptive behavior treatment guidance, administered by physician or other qualified health care professional (without the patient present), face-to-face with multiple sets of guardians/caregivers, each 15 minutes


name: Group adaptive behavior treatment with protocol modification, administered by physician or other qualified health care professional, face-to-face with multiple patients, each 15 minutes


name: Digitally Stored Data Services/Remote Physiologic Monitoring


name: Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days


name: Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial


name: Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; set-up and patient education on use of equipment


name: Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment


name: Initial setup and patient education on use of device for remote monitoring of blood pressure


name: Initial setup and patient education on use of device for remote monitoring of physiologic parameter


name: Initial setup and patient education on use of device for remote monitoring of pulse oximetry


name: Initial setup and patient education on use of device for remote monitoring of weight


name: Initial setup and patient education on use of devices for remote monitoring of respiratory flow rate, with daily recording transmission


name: Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days


name: Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days


name: Initial supply of device for remote monitoring of blood pressure, with daily recording transmission, per 30 days


name: Initial supply of device for remote monitoring of physiologic parameter, with daily programmed alert transmission, per 30 days


name: Initial supply of device for remote monitoring of physiologic parameter, with daily recording transmission, per 30 days


name: Initial supply of device for remote monitoring of pulse oximetry, with daily recording transmission, per 30 days


name: Initial supply of device for remote monitoring of weight, with daily recording transmission, per 30 days


name: Initial supply of devices for remote monitoring of blood pressure, with daily programmed alert transmission, per 30 days


name: Initial supply of devices for remote monitoring of pulse oximetry, with daily programmed alert transmission, per 30 days


name: Initial supply of devices for remote monitoring of respiratory flow rate, with daily programmed alert transmission, per 30 days


name: Initial supply of devices for remote monitoring of respiratory flow rate, with daily recording transmission, per 30 days


name: Initial supply of devices for remote monitoring of weight, with daily programmed alert transmission, per 30 days


name: Interprofessional Telephone/Internet/Electronic Health Record Consultations


name: Interprofessional telephone/Internet/electronic health record assessment and management service provided by a consultative physician or other qualified health care professional, including a written report to the patient's treating/requesting physician or other qualified health care professional, 5 minutes or more of medical consultative time


name: Telephone or internet referral service, 30 minutes


name: remote physiologic monitoring treatment management services


name: Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes


name: Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 30 minutes provided personally by a physician or other qualified health care professional, per calendar month.


name: Insertion of implant into subtalar (below ankle) foot joint


name: Behavior identification supporting assessment for patient exhibiting destructive behavior, each 15 minutes of technicians' face-to-face time


name: Adaptive behavior treatment with protocol modification for patient exhibiting destructive behavior, each 15 minutes of technicians' face-to-face time


name: Endovenous femoral-popliteal arterial revascularization, with transcatheter placement of intravascular stent graft(s) and closure by any method, including percutaneous or open vascular access, ultrasound guidance for vascular access when performed, all catheterization(s) and intraprocedural roadmapping and imaging guidance necessary to complete the intervention, all associated radiological supervision and interpretation, when performed, with crossing of the occlusive lesion in an extraluminal fashion


name: Reopening of arteries in thigh and behind knee with placement of stent via catheter using imaging guidance


name: Macular pigment optical density measurement by heterochromatic flicker photometry, unilateral or bilateral, with interpretation and report


name: Measurement of pigment density in retinas with interpretation and report


name: Near infrared dual imaging (ie, simultaneous reflective and transilluminated light) of meibomian glands, unilateral or bilateral, with interpretation and report


name: Near infrared dual imaging of tear glands with interpretation and report


name: Electroretinography (ERG) with interpretation and report, pattern (PERG)


name: Pattern recording of retinal electrical responses to external stimuli with interpretation and report


name: Removal of implant from tunnel on outer side of foot (sinus tarsi)


name: Removal and reinsertion of sinus tarsi implant


name: Removal and reinsertion of implant from tunnel on outer side of foot (sinus tarsi)


name: Extracorporeal shock wave for integumentary wound healing, including topical application and dressing care; initial wound


name: High energy shock wave therapy for initial wound of outer body surface


name: Extracorporeal shock wave for integumentary wound healing, including topical application and dressing care; each additional wound (List separately in addition to code for primary procedure)


name: High energy shock wave therapy for additional wound of outer body surface


name: Insertion of wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming, and imaging supervision and interpretation, when performed


name: Insertion of wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming, and imaging supervision and interpretation, when performed; complete system (includes electrode and generator [transmitter and battery])


name: Insertion of complete wireless heart stimulator system for pacing of lower left chamber of heart


name: Insertion of wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming, and imaging supervision and interpretation, when performed; electrode only


name: Insertion of electrode of wireless heart stimulator system for pacing of lower left chamber of heart


name: Insertion of wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming, and imaging supervision and interpretation, when performed; both components of pulse generator (battery and transmitter) only


name: Insertion of pulse generator components of wireless heart stimulator system for pacing of lower left chamber of heart


name: Removal of pulse generator for wireless cardiac stimulator for left ventricular pacing; battery component only


name: Removal of pulse generator components of wireless heart stimulator system for pacing of lower left chamber of heart


name: Removal and replacement of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; both components (battery and transmitter)


name: Removal and replacement of pulse generator for wireless cardiac stimulator for left ventricular pacing, including device interrogation and programming; battery component only


name: Interrogation device evaluation (in person) with analysis, review and report, includes connection, recording, and disconnection per patient encounter, wireless cardiac stimulator for left ventricular pacing


name: Evaluation of parameters of wireless heart stimulator system for pacing of lower left chamber of heart including connection, recording, disconnection, and analysis


name: Programming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, including review and report, wireless cardiac stimulator for left ventricular pacing


name: Evaluation, testing, and programming adjustment of wireless heart stimulator system for pacing of lower left chamber of heart with qualified health care professional analysis, review, and report


name: Intraprocedural coronary fractional flow reserve (FFR) with 3D functional mapping of color-coded FFR values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention (List separately in addition to code for primary procedure)


name: Measurement fractional flow reserve in arteries of heart with 3D functional mapping during procedure


name: Endovenous catheter directed chemical ablation with balloon isolation of incompetent extremity vein, open or percutaneous, including all vascular access, catheter manipulation, diagnostic imaging, imaging guidance and monitoring


name: Chemical destruction of insufficient vein of arm or leg via catheter using imaging guidance


name: Insertion or replacement of intracardiac ischemia monitoring system, including testing of the lead and monitor, initial system programming, and imaging supervision and interpretation


name: Insertion or replacement of intracardiac ischemia monitoring system, including testing of the lead and monitor, initial system programming, and imaging supervision and interpretation; complete system (electrode and implantable monitor)


name: Insertion or replacement of complete monitoring system for deficient blood flow in heart muscle using imaging guidance


name: Insertion or replacement of intracardiac ischemia monitoring system, including testing of the lead and monitor, initial system programming, and imaging supervision and interpretation; electrode only


name: Insertion or replacement of electrode of monitoring system for deficient blood flow in heart muscle with imaging supervision and interpretation


name: Insertion or replacement of intracardiac ischemia monitoring system, including testing of the lead and monitor, initial system programming, and imaging supervision and interpretation; implantable monitor only


name: Programming device evaluation (in person) of intracardiac ischemia monitoring system with iterative adjustment of programmed values, with analysis, review, and report


name: Evaluation, testing, and programming adjustment of monitoring system for deficient blood flow in heart muscle with analysis, review, and report


name: Interrogation device evaluation (in person) of intracardiac ischemia monitoring system with analysis, review, and report


name: Evaluation of parameters of monitoring system for deficient blood flow in heart muscle with analysis, review, and report


name: Removal of intracardiac ischemia monitoring system, including all imaging supervision and interpretation


name: Removal of intracardiac ischemia monitoring system, including all imaging supervision and interpretation; complete system (electrode and implantable monitor)


name: Removal of complete monitoring system for deficient blood flow in heart muscle with imaging supervision and interpretation


name: Removal of intracardiac ischemia monitoring system, including all imaging supervision and interpretation; electrode only


name: Removal of electrode of monitoring system for deficient blood flow in heart muscle with imaging supervision and interpretation


name: Removal of intracardiac ischemia monitoring system, including all imaging supervision and interpretation; implantable monitor only


name: Removal of implantable monitor of monitoring system for deficient blood flow in heart muscle with imaging supervision and interpretation


name: Chimeric antigen receptor T-cell immunotherapy


name: Chimeric antigen receptor T-cell (CAR-T) therapy; harvesting of blood-derived T lymphocytes for development of genetically modified autologous CAR-T cells, per day


name: Harvesting of blood-derived T white blood cells (T lymphocytes) for chimeric antigen receptor T-cell therapy, per day


name: Chimeric antigen receptor T-cell (CAR-T) therapy; preparation of blood-derived T lymphocytes for transportation (eg, cryopreservation, storage)


name: Preparation of blood-derived T white blood cells (T lymphocytes) for transportation for chimeric antigen receptor T-cell therapy


name: Chimeric antigen receptor T-cell (CAR-T) therapy; receipt and preparation of CAR-T cells for administration


name: Receipt and preparation of blood-derived T white blood cells (T lymphocytes) for chimeric antigen receptor T-cell therapy


name: Chimeric antigen receptor T-cell (CAR-T) therapy; CAR-T cell administration, autologous


name: Administration of blood-derived T white blood cells (T lymphocytes) for chimeric antigen receptor T-cell therapy


name: Myocardial imaging by magnetocardiography (MCG) for detection of cardiac ischemia, by signal acquisition using minimum 36 channel grid, generation of magnetic-field time-series images, quantitative analysis of magnetic dipoles, machine learning-derived clinical scoring, and automated report generation, single study


name: Imaging of heart muscle using magnetocardiography to detect deficient blood flow, single study


name: Myocardial imaging by magnetocardiography (MCG) for detection of cardiac ischemia, by signal acquisition using minimum 36 channel grid, generation of magnetic-field time-series images, quantitative analysis of magnetic dipoles, machine learning-derived clinical scoring, and automated report generation, single study; interpretation and report


name: Interpretation and report of imaging of heart muscle using magnetocardiography to detect deficient blood flow


name: Oncology, prostate cancer, mRNA expression assay of 12 genes (10 content and 2 housekeeping), RT-PCR test utilizing blood plasma and urine, algorithms to predict high-grade prostate cancer risk


name: Oncology (urothelial), mRNA, gene expression profiling by real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm reported as a risk score for having urothelial carcinoma


name: Oncology (urothelial), mRNA, gene expression profiling by real-time quantitative PCR of five genes (MDK, HOXA13, CDC2 [CDK1], IGFBP5, and CXCR2), utilizing urine, algorithm reported as a risk score for having recurrent urothelial carcinoma


name: therapeutic balloon-guided endoscopic procedure


name: diagnostic balloon-guided endoscopic procedure


name: breath volatile organic compounds collection/testing


name: spatially fractionated radiation therapy


name: tandem high-dose chemotherapy with autologous stem cell rescue


name: high-dose chemotherapy with autologous stem cell rescue


name: reduced-intensity, double-unit umbilical cord blood transplantation


name: tissue-oxygen-level-dependent functional magnetic resonance imaging


name: straight wire excision of transformation zone


name: endoscopic 4D elastic light-scattering fingerprinting


name: CT-guided microcoil lung nodule localization


name: virtual bronchoscopy transbronchial fine-needle aspiration


name: endoscopic ultrasound-guided fine-needle aspiration/lung


name: dual-energy contrast-enhanced digital mammography


name: heavy water dna-labeling-based cell proliferation assay


name: cap-assisted colonoscopy with chromoendoscopy


name: autologous GM-CSF-secreting melanoma vaccine


name: serine/threonine tyrosine kinase targeted therapy


name: matrix metalloprotease inhibitor therapy


name: endoscopic transanal vacuum-assisted rectal drainage


name: AR ligand binding domain-targeting agent AZD3514


name: Administration of hyperthermic antineoplastic agent into thoracic cavity


name: computed tomography-guided optical sensor-guided percutaneous fine-needle aspiration


name: lutetium Lu 177 peptide receptor radionuclide


name: immediate-release oral liquid formulation oxymorphone hydrochloride


name: indium In 111 HER2-specific high-affinity protein ABY-025


name: hedgehog signaling pathway-targeted therapy


name: hedgehog signaling pathway inhibitor therapy


name: hedgehog signaling pathway antagonist therapy


name: Notch signaling pathway-targeted therapy


name: Notch signaling pathway inhibitor therapy


name: liposome-encapsulated recombinant human enzyme Cu/Zn superoxide-dismutase


name: endoscopic ultrasound-guided ganglia neurolysis


name: computed tomography with radiolabeled targeting agents


name: amide-proton transfer magnetic resonance imaging


name: lattice extreme ablative dose radiation therapy


name: hyperpolarized noble gas magnetic resonance imaging


name: magnetic endoscopic imaging-guided colonoscopy


name: electronic nicotine delivery systems therapy


name: low-coherence enhanced backscattering spectroscopy


name: real-time intra-fraction tumor tracking during radiation therapy


name: endoscopic ultrasound-guided keyhole biopsy


name: 4-dimensional positron emission tomography/computed tomography


name: endoscopic ultrasound-guided core needle biopsy


name: endoscopic ultrasound-guided single incision needle knife biopsy


name: radial endobronchial ultrasound-guided cryobiopsy


name: 3-dimensional contrast-enhanced ultrasound imaging


name: low-dose involved-field radiation therapy


name: Chinese herbal formulation ChangTai Keli


name: delayed-release formulation doxycycline hyclate


name: allogeneic fecal microbiota transplantation


name: Clostridium butyricum CBM 588 Probiotic Strain


name: oral hyaluronic acid/chondroitin sulfate/curcumin/quercetin


name: Pathologist interpretation of Bronchial specimen tests


name: CD59 deficient RBC/100 cells in red blood cells (lab test)


name: Hemoglobin electrophoresis panel in Blood (lab test)


name: Pathologist interpretation of Body fluid tests


name: Hydrogenated talloweth-60 myristyl glycol


name: ZINC OXIDE 100 g in 1000 g / TITANIUM DIOXIDE 55 g in 1000 g TOPICAL CREAM [EltaMD UV Pure SPF47]


name: ZINC OXIDE 70 g in 1000 g / OCTINOXATE 75 g in 1000 g TOPICAL LOTION [EltaMD UV Facial SPF30 Plus]


name: ZINC OXIDE 90 g in 1000 g / OCTINOXATE 75 g in 1000 g TOPICAL LOTION [EltaMD UV Clear Tinted SPF46]


name: PETROLATUM 600 g in 1000 g TOPICAL OINTMENT [EltaMD Laser Balm]


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Hailey Fe 1.5/30 28 Day]


name: AVOBENZONE 1.6 g in 100 g / HOMOSALATE 4 g in 100 g / OCTOCRYLENE 4.5 g in 100 g TOPICAL SPRAY [Banana Boat]


name: sodium urate/total in stone by infrared spectroscopy (lab test)


name: ZINC OXIDE 90 g in 1000 g / OCTINOXATE 75 g in 1000 g / octisalate 50 g in 1000 g TOPICAL LOTION [EltaMD UV Sport SPF50]


name: ZINC OXIDE 90 g in 1000 g / TITANIUM DIOXIDE 70 g in 1000 g TOPICAL LOTION [EltaMD UV Physical SPF41]


name: Acuicyn Antimicrobial Eyelid and Eyelash Hygiene Solution


name: CVS Gentle Infant Formula with Iron Powder for Suspension


name: Health Mart UltiCare Micro 32G 5/32 inch Pen Needle


name: Health Mart UltiCare Mini 31G 1/4 inch Pen Needle


name: Health Mart UltiCare Short 31G 5/16 inch Pen Needle


name: Nutricia PhenylAde GMP Ready Enteral Suspension


name: One Drop Blood Glucose Monitoring System


name: PediaSure Grow & Gain Enteral Suspension (s'mores)


name: TRUEplus 5-Bevel 29G 1/2 inch Pen Needle


name: TRUEplus 5-Bevel 31G 1/4 inch Pen Needle


name: TRUEplus 5-Bevel 31G 3/16 inch Pen Needle


name: TRUEplus 5-Bevel 31G 5/16 inch Pen Needle


name: TRUEplus 5-Bevel 32G 5/32 inch Pen Needle


name: Niacinamide 2.0 g in 100 g / Adenosine 0.04 g in 100 g TOPICAL PATCH [TIME RETURN MELATONIN]


name: Ointment, Multi Ingredient Topical application Ointment [DERMULCERA]


name: maltodextrin/fructose 0.68 kcal/mL ORAL LIQUID (ML)


name: stabilizer for moxetumomab pasudotox-tdfk INTRAVEN VIAL (ML)


name: thrombin (bovine)/gelatin sponge,absorbable 5,000 unit TOPICAL SYRINGE KIT (EA)


name: cream base no.229 TRANSDERM CREAM (GRAM)


name: nutritional therapy for tyrosinemia without iron 80 gram-324 kcal/100 gram ORAL POWDER IN PACKET (EA)


name: emollient combination no.101 TOPICAL LOTION (GRAM)


name: glucose sensor,implantable,continuous/dexamethasone acetate SUBCUT EACH


name: infant formula with iron/docosahexaenoic acid/arachidonic ac 2.16 gram-5.3 gram-10.9 gram/100 kcal ORAL POWDER (GRAM)


name: pediatric nutrit,milk based,iron/docosahex.acid/arachid.acid 6 gram-170 kcal/41 gram ORAL POWDER (GRAM)


name: kit for prep Tc-99m/bicisate di-HCl 0.9 mg INTRAVEN VIAL (EA)


name: kit for the preparation of Tc-99m/tilmanocept 250 mcg INJECTION VIAL (EA)


name: ZINC OXIDE 50 g in 1000 g / OCTINOXATE 75 g in 1000 g TOPICAL LOTION [EltaMD UV Lip Balm SPF31]


name: ZINC OXIDE 90 g in 1000 g / OCTINOXATE 75 g in 1000 g TOPICAL LOTION [EltaMD UV Shield SPF45]


name: stabilizer for moxetumomab pasudotox-tdfk


name: OCTINOXATE 2.4 mg in 40 mL / TITANIUM DIOXIDE 1.608 mg in 40 mL / OCTISALATE 0.8 mg in 40 mL / ZINC OXIDE 0.768 mg in 40 mL TOPICAL CREAM [Be Beautiful Pure Make Up Base Purple]


name: glycerin / lidocaine / petrolatum / phenylephrine


name: ISOPROPYL ALCOHOL 30 mg in 1 mL TOPICAL SOLUTION


name: Formula, Infant Oral Powder for Suspension [SIMILAC ADVANCE LAMEHADRIN W/IRON]


name: Medical Food Oral Suspension [PEDIASURE GROW & GAIN]


name: Medical Food Oral Powder [TYR LOPHLEX GMP MIX-IN]


name: Medical Food Oral Powder for Solution [PKU SPHERE20]


name: Formula, Infant Oral Powder for Suspension [SIMILAC LAMEHADRIN TODDLER]


name: Technetium Tc 99m Bicisate;Technetium Tc 99m Bicisate Intravenous Kit


name: Titanium Dioxide 225 mg in 1 g / Zinc Oxide 225 mg in 1 g TOPICAL POWDER [Sunforgettable Total Protection Brush-On Shield SPF 50]


name: Titanium Dioxide 79 mg in 1 mL / Zinc Oxide 67 mg in 1 mL TOPICAL LIQUID [Total Eye 3-In-1 Renewal Therapy SPF 35]


name: Rhizopus arrhizus allergenic extract / Rhizopus stolonifer allergenic extract


name: PANTHENOL 1 g in 500 g / MENTHOL 1.5 g in 500 g / SALICYLIC ACID 1.25 g in 500 g TOPICAL SOLUTION [Perilla Fo ti Conditioner]


name: BARRIER,EASE THIN CURVE STRIPS 3CM X 9CM C#422163


name: CATHETER,INTERMITTENT 10FR LOFRIC SENSE #4161050


name: CATHETER,FOLEY SILICONE DOVER 22FR 5ML COVIDIEN #8887605221


name: CATHETER,FOLEY SILICONE DOVER 18FR 5ML COVIDIEN #8887605189


name: CATHETER,INTERMITTENT 16FR FEMALE COLOPLAST #28516


name: CATHETER,INTERMITTENT COUDE 14FR COLOPLAST #28494


name: CATHETER,INTERMITTENT COUDE 12FR COLOPLAST #28492


name: CATHETER,FOLEY 18FR 30ML RUSCH #662530-000180


name: Alternaria alternata allergenic extract / Aspergillus fumigatus allergenic extract


name: Dimethicone 3.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL CREAM [Dr COSIGN CCE Premium Repair]


name: Dimethicone 8.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL LOTION [Dr COSIGN CCE Intensive Regenerating]


name: Fusarium moniliforme antigen / Haematonectria haematococca allergenic extract


name: CATHETER,EXTERNAL INTERM BARD #33103/33303


name: CATHETER,INTERMITTENT VAPRO TOUCH FREE 14FR H#73144


name: DRESSING,MEDLINE ISLAND 4IN X 8IN #MSC3248


name: CATHETER,EXTERNAL X-LRG BARD #33105/33305


name: CATHETER,INTERMITTENT 12FR FEMALE COLOPLAST #28512


name: Mucor circinelloides f. lusitanicus allergenic extract / Mucor plumbeus allergenic extract


name: Mucor circinelloides f. lusitanicus allergenic extract / Rhizopus stolonifer allergenic extract


name: camphor / Capsicum oleoresin / menthol / methyl salicylate


name: Candida albicans allergenic extract / neurospora intermedia allergenic extract


name: Zinc Oxide 66 mg in 1 mL TOPICAL LIQUID [Lip Shine SPF35 Sunscreen]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Old Spice Wilderness with Lavender]


name: OCTINOXATE 6.9 g in 100 mL / OCTISALATE 3 g in 100 mL / ZINC OXIDE 4 g in 100 mL TOPICAL CREAM [CONTROL CORRECTIVE INTENSIVE SKIN BRIGHTENING SPF-30 SUNSCREEN]


name: TITANIUM DIOXIDE 2.5 g in 100 mL / ZINC OXIDE 6 g in 100 mL TOPICAL CREAM [CONTROL CORRECTIVE TINTED MOISTURIZER SPF-30 SUNSCREEN]


name: ALUMINUM CHLOROHYDRATE ANHYDROUS 9 g in 5 g CUTANEOUS SPRAY


name: ALUMINUM CHLOROHYDRATE ANHYDROUS 9 g in 5 g INFILTRATION SPRAY


name: OCTINOXATE 74.9 mg in 1 mL TOPICAL LOTION [DIORSKIN NUDE AIR Nude Healthy Glow Ultra-Fluid Serum Foundation with Sunscreen Broad Spectrum SPF25 020 Light Beige]


name: Dimethicone;Triamcinolone Acetonide 5%; 0.1% Multiple Routes Kit


name: SmartMouth Mouthwash Clinical DDS Formula KIT


name: AVOBENZONE 2.3 g in 100 g / HOMOSALATE 9.2 g in 100 g / OCTISALATE 4.3 g in 100 g TOPICAL STICK [KLENSKIN BROAD SPECTRUM SUNSCREEN SPF-30]


name: Cetylpyridinium Chloride 500 mg in 20 mL DENTAL LIQUID [SmartMouth Clinical DDS Solution 2 Mint]


name: OCTINOXATE 40 mg in 1 mL TOPICAL LIQUID [YANBAL BASE LIQUIDA MATIFICANTE MATTIFYING FOUNDATION SUNSCREEN BROAD SPECTRUM SPF 15 TONO 1]


name: PANTHENOL 1 g in 500 g / MENTHOL 1.5 g in 500 g / SALICYLIC ACID 1.25 g in 500 g TOPICAL SHAMPOO [Perilla Fo ti]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 156 mg in 1 g TOPICAL STICK [Mens Speed Overtime Odor Control with Charcoal - antiperspirant/deodorant]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 154 mg in 1 g TOPICAL STICK [Mens Speed Stick Irish Spring Celtic Ice - antiperspirant/deodorant]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 70 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Sport Anthelios Activewear Broad Spectrum SPF 60 Sunscreen]


name: Octinoxate 0.075 g in 1 g / Zinc Oxide 0.049 g in 1 g TOPICAL LIPSTICK [LBEL ULTRA BALM MOISTURIZING PROTECTIVE BALM FOR LIPS SPF 20 Cerise Brise / Red]


name: TITANIUM DIOXIDE 32.8 mg in 1 mL / ZINC OXIDE 124.8 mg in 1 mL TOPICAL CREAM [bareMinerals Complexion Rescue Defense Radiant Protective Veil Broad Spectrum SPF 30 Soft Radiance]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 15 g in 100 g TOPICAL STICK [Old Spice Fiji with Palm Tree]


name: Bermuda grass smut allergenic extract / Johnson grass smut allergenic extract


name: Excedrin Extra Strength and Excedrin Tension Headache KIT


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL TOPICAL CREAM [CLINIQUE SMART BROAD SPECTRUM SPF 15 CUSTOM-REPAIR MOISTURIZER DRY COMBINATION]


name: OCTINOXATE 0.075 g in 1 g / ZINC OXIDE 0.0392 g in 1 g TOPICAL LIPSTICK [LBEL CONCENTRE TOTAL LABIOS GLOBAL PERFECTION SPF 20 BURDEOS/Red]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Hydraboost Moisturizer SPF 30]


name: Octinoxate 1.4 g in 20 mL / Octocrylene 1.0 g in 20 mL / Octisalate 0.9 g in 20 mL TOPICAL STICK [Ra Sence Loe Cure Air light UV shield Sun]


name: Octinoxate 4.87 g in 65 mL / Titanium Dioxide 2.76 g in 65 mL / Octocrylene 1.95 g in 65 mL / Avobenzone 1.62 g in 65 mL TOPICAL CREAM [Belucie Luxury UV Sun]


name: OCTINOXATE 0.05 g in 1 g / ZINC OXIDE 0.042 g in 1 g TOPICAL CREAM [ESIKA PRO NATURAL MATTIFYING FOUNDATION ADAPTABLE TO YOUR SKIN TONE SPF 20 Claro 1/Beige]


name: Niacinamide 0.034 g in 1.66 g / Adenosine 0.0006 g in 1.66 g TOPICAL PATCH [MIZON SNAIL REPAIR INTENSIVE GOLD EYE GE L]


name: ZINC OXIDE 200 mg in 1 g TOPICAL CREAM [Sun Defense Mineral Sunscreen SPF 30 Face]


name: psychiatric therapy for drug detoxification


name: Pathologist interpretation of Blood tests


name: Pathologist interpretation of Unspecified specimen tests


name: pre-procedure checklist: abstinence from smoking reported/verified


name: pre-procedure teaching: abstinence from smoking


name: corticosteroid injection into sacroiliac joint


name: corticosteroid injection into right sacroiliac joint


name: corticosteroid injection into left sacroiliac joint


name: surgeon's pre-op evaluation: preoperative assessment documented


name: documented: communication to clinician treating comorbid condition


name: discussed decreasing or eliminating juice intake


name: discussed no juice by bottle or sippy cup


name: influenza virus vaccine injection, Madin-Darby canine kidney, preservative-free, quadrivalent


name: influenza virus vaccine injection, Madin-Darby canine kidney, with preservative, quadrivalent


name: anticipatory guidance: use of xylitol products


name: Hepatitis B vaccine CpG, recombinant, adjuvanted, 18 years and above


name: influenza virus vaccine, trivalent, adjuvanted, preservative-free


name: rabies vaccine, chicken fibroblast culture


name: anticipatory guidance: discipline setting clear rules and expectations


name: anticipatory guidance: using distraction for tantrums


name: guidance: concerns about family adjustment to newborn


name: anticipatory guidance: talking with child about pictures in books/magazines


name: anticipatory guidance: age-appropriate diet no honey before age 1


name: anticipatory guidance: age-appropriate diet no solid foods until age 4-6 months


name: anticipatory guidance: limiting bottle to water only


name: anticipatory guidance: establishing a dental home


name: anticipatory guidance: wearing mouth guard for sports


name: anticipatory guidance: protective equipment hearing protection


name: anticipatory guidance: body image issues


name: anticipatory guidance: reporting mental health concerns


name: anticipatory guidance: sport / activity safety


name: anticipatory guidance: medication safety


name: anticipatory guidance: not sharing prescription medications


name: anticipatory guidance: knowing child's friends


name: anticipatory guidance: smoke-free environment


name: anticipatory guidance: not leaving baby alone in tub


name: anticipatory guidance: not drinking hot liquids while holding baby


name: anticipatory guidance: safety rules when with other adults


name: anticipatory guidance: sun exposure protection


name: anticipatory guidance: encouraging school


name: anticipatory guidance: helping with homework


name: anticipatory guidance: abstinence from sex


name: guidance: concerns about toilet training waiting until child is ready


name: anticipatory guidance: limiting screen time to 1-2 hours per day


name: anticipatory guidance: pediatric handout given


name: serial manipulation and casting, clubfoot cast


name: anticipatory guidance: stimulation - encouraging child to read


name: anticipatory guidance: socialization opportunities with other children


name: parent education: teaching child about personal hygiene


name: anticipatory guidance: demonstrating anger management techniques


name: anticipatory guidance: discipline for teaching rather than punishment


name: anticipatory guidance: encouraging independence


name: anticipatory guidance: limiting saying 'no' to child


name: parent education: showing respect to child


name: parent education: regular family activities


name: anticipatory guidance: talking to child using simple words


name: anticipatory guidance: showing affection


name: anticipatory guidance: avoiding all-terrain vehicles


name: anticipatory guidance: precautions against choking


name: anticipatory guidance: choking risk of plastic bags


name: anticipatory guidance: choking risk of small objects


name: anticipatory guidance: lead poisoning risks


name: anticipatory guidance: safe after-school care and activities


name: anticipatory guidance: supervision of outdoor play


name: anticipatory guidance: teaching conflict resolution skills


name: anticipatory guidance: communicating with teachers


name: anticipatory guidance: curiosity about body using proper terms


name: anticipatory guidance: encouraging play with peers


name: anticipatory guidance: encouraging healthy friendships


name: anticipatory guidance: alternatives to television


name: anticipatory guidance: no electronic media in bedroom


name: anticipatory guidance: modeling proper grammar and pronunciation


name: patient counseling: discussion of plans for returning to work


name: observation following rape: examination of adult victim


name: observation following rape: examination of child victim


name: referral to infectious disease specialist


name: referral to pediatric infectious disease specialist


name: request consultation with pediatric allergist


name: request consultation with pediatric audiologist


name: request consultation with pediatric dentist


name: request consultation with pediatric dermatologist


name: request consultation with pediatric geneticist


name: request consultation with pediatric gynecologist


name: request consultation with pediatric hospitalist


name: request consultation with pediatric immunologist


name: request consultation with pediatric neurosurgeon


name: request consultation with pediatric oncologist


name: request consultation with pediatric orthopedic surgeon


name: request consultation with pediatric plastic surgeon


name: request consultation with pediatric psychologist


name: request consultation with pediatric speech therapist


name: request consultation with pediatric urologist


name: request consultation with sports medicine specialist


name: Td vaccine, 2 Lf tetanus, 2 Lf diphtheria, preservative free, adsorbed


name: Td vaccine, 5 Lf tetanus, 5 Lf diphtheria, preservative free, adsorbed


name: prophylactic antibiotic completely infused prior to proximal tourniquet inflation


name: interprofessional telephone/internet/EHR consultation with verbal and written report


name: interprofessional telephone/internet/EHR consultation with written report


name: interprofessional telephone/internet/EHR consultation with written report, 5 minutes or longer


name: interprofessional telephone/internet/EHR referral, 30 minutes


name: initial set-up of and patient education about remote physiologic monitoring


name: supply of remote physiologic monitoring device for recording or transmission, each 30 days


name: remote physiologic monitoring treatment management services, 20 minutes or longer


name: coordination of chronic care services, minimum of 20 minutes per month


name: coordination of chronic care services by physician, first 30 minutes per month


name: permanent right ventricular leadless pacemaker


name: Transcatheter replacement of permanent leadless right ventricular pacemaker


name: insertion of subcutaneous cardiac rhythm monitor


name: aortic valve replacement by Ross-Konno procedure


name: aortic aneurysm repair with hemiarch graft


name: PICC insertion with imaging guidance, child under five years of age


name: PICC insertion with imaging guidance, child five years of age or older


name: complete same site replacement of PICC with imaging guidance


name: replacement of percutaneous gastrostomy drainage tube with revision of gastrostomy tract


name: dilation of existing percutaneous nephrostomy tract with imaging guidance


name: dilation of existing percutaneous nephrostomy tract, imaging guidance, with new access into renal collecting system


name: camphorated opium + glycyrrhiza fluid extract


name: high daily dosage of glucocorticoid therapy with potential for bone loss


name: inferior vena cava permanent filter placement


name: NAA with probe detection for Candida DNA


name: NAA with probe detection for Candida DNA in vaginal fluid


name: NAA with probe detection for Candida albicans DNA


name: NAA with probe detection for Candida albicans DNA in blood


name: NAA with probe detection for Candida albicans DNA in vaginal fluid


name: NAA with probe detection for Candida glabrata DNA


name: NAA with probe detection for Candida glabrata DNA in blood


name: NAA with probe detection for Candida glabrata DNA in vaginal fluid


name: NAA with probe detection for Candida tropicalis DNA


name: NAA with probe detection for Candida tropicalis DNA in blood


name: NAA with probe detection for Candida tropicalis DNA in vaginal fluid


name: NAA with probe detection for Candida parapsilosis DNA


name: NAA with probe detection for Candida parapsilosis DNA in blood


name: NAA with probe detection for Candida parapsilosis DNA in vaginal fluid


name: NAA with probe detection for Candida lusitaniae DNA


name: NAA with probe detection for Candida lusitaniae DNA in vaginal fluid


name: NAA with probe detection for Candida krusei DNA


name: NAA with probe detection for Candida krusei DNA in blood


name: NAA with probe detection for Candida krusei DNA in vaginal fluid